<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Clexane preparations; Enoxaparin" /><meta name="IX" content="Clexane preparations; Enoxaparin" /><title>Clexane®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2776.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2776.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2776.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2760.htm">2.8 Anticoagulants and protamine</a> &gt; <a href="2761.htm">2.8.1 Parenteral anticoagulants</a> &gt; <a href="2772.htm">Low molecular weight heparins</a> &gt; <a href="2775.htm">ENOXAPARIN SODIUM</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2773.htm" title="Previous: DALTEPARIN SODIUM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2777.htm" title="Next: TINZAPARIN SODIUM">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a393016.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin Sodium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Antithrombotic Agents 20:12 &gt; Anticoagulants 20:12.04 &gt; Heparins 20:12.04.16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21230-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Enoxaparin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: E &gt; Interactions of Enoxaparin</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="2772.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Low molecular weight heparins</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants</p></div></li><li><a href="2775.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ENOXAPARIN SODIUM</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Low molecular weight heparins</p></div></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2772.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Low molecular weight heparins</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2775.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ENOXAPARIN SODIUM</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Low molecular weight heparins</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2776.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Clexane®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Low molecular weight heparins &gt; ENOXAPARIN SODIUM</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0632.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; E</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a597010.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin Sodium</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; E</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/e02-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin sodium</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; E</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/13424-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin Sodium</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03588.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Enoxaparin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; E &gt; EN</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D887.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Enoxaparin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; E</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2775">ENOXAPARIN SODIUM</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i227.htm" title="Go to appendix 1">Enoxaparin</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see notes above and under preparations</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see under <a title="target-block: Heparin cautions" href="2762.htm#_2762.1"><span>Heparin</span></a> and notes above; low body-weight (increased risk of bleeding)</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">see under <a title="target-block: Heparin contra-indications" href="2762.htm#_2762.2"><span>Heparin</span></a></p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">manufacturer advises caution—no information available</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">risk of bleeding increased; reduce dose if eGFR less
than 30 mL/minute/1.73 m<sup>2</sup>—consult product literature for
details; monitoring of anti-factor Xa may be required; use of unfractionated
heparin may be preferable</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">not known to be harmful; see also <a title="BNF:target-block: heparin in pregnancy" href="11290.htm#_11290.1">Pregnancy</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">manufacturer advises avoid—no information available</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see under <span>Heparin</span></p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See under preparation below</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_2776" style="margin: 0 0 0 20px;"><h1 class="title">Clexane®<span> (<a href="appendix-112803-S.htm#m686">Sanofi-Aventis</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, <span>enoxaparin</span> sodium 100 mg/mL, net price 20-mg (0.2-mL, 2000-units) syringe =
£3.03, 40-mg (0.4-mL, 4000-units) syringe = £4.04, 60-mg (0.6-mL,
6000-units) syringe = £4.57, 80-mg (0.8-mL, 8000-units) syringe =
£6.49, 100-mg (1-mL, 10 000-units) syringe = £8.04; 300 mg (3-mL,
30 000-units) vial (<span class="cZ">Clexane® Multidose</span>) = £21.33;
150 mg/mL (<span class="cZ">Clexane® Forte</span>), 120-mg (0.8-mL, 12 000-units)
syringe = £9.77, 150-mg (1-mL, 15 000-units) syringe = £11.10<div class="cAO"><span class="cAG">Excipients </span> include benzyl alcohol (in 300 mg multidose vials) (avoid in neonates, see <a title="BNF:target-block: Excipients" href="29404.htm#_120000">Excipients</a>)</div><div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">prophylaxis of deep-vein thrombosis especially in surgical
patients, <span class="cU">by subcutaneous injection</span>, <i>moderate
risk</i>, 20 mg (2000 units) approx. 2 hours before surgery then
20 mg (2000 units) every 24 hours; <i>high risk</i> (e.g.
orthopaedic surgery), 40 mg (4000 units) 12 hours before surgery then
40 mg (4000 units) every 24 hours</p></div><div class="cAF"><p class="cAF">Prophylaxis of deep-vein thrombosis in medical patients, <span class="cU">by subcutaneous injection</span>, 40 mg (4000 units) every 24 hours</p></div><div class="cAF"><p class="cAF">Treatment of deep-vein thrombosis or pulmonary embolism, <span class="cU">by subcutaneous injection</span>, 1.5 mg/kg (150 units/kg) every
24 hours until adequate oral anticoagulation established</p></div><div class="cAF"><p class="cAF">Treatment of acute ST-segment elevation myocardial infarction, <span class="cAK">adult</span> under 75 years, <span class="cU">by intravenous injection</span>, 30 mg (3000 units) followed <span class="cU">by subcutaneous injection</span>, 1 mg/kg (100 units/kg), then <span class="cU">by subcutaneous injection</span>, 1 mg/kg every 12 hours for up to 8 days (max. 100 mg (10 000 units)
for first two subcutaneous doses only); <span class="cAK">elderly</span> over 75 years, <span class="cU">by subcutaneous injection</span> <i>only</i>, 750 micrograms/kg (75 units/kg) every 12 hours (max.
75 mg (7500 units) for first two doses only); patients undergoing
percutaneous coronary intervention, additional dose, <span class="cU">by intravenous
injection</span>, 300 micrograms/kg (30 units/kg) at time of procedure
if last subcutaneous dose given more than 8 hours previously</p><div class="cAV"><h3>Note</h3> <p class="cAX">When administered in conjunction with a thrombolytic,
enoxaparin should be given between 15 minutes before and 30 minutes
after the start of thrombolytic therapy</p></div></div><div class="cAF"><p class="cAF">Unstable angina and non-ST-segment-elevation myocardial
infarction, <span class="cU">by subcutaneous injection</span>, 1 mg/kg (100 units/kg)
every 12 hours usually for 2–8 days (minimum 2 days)</p></div><div class="cAF"><p class="cAF">Prevention of clotting in extracorporeal circuits, consult
product literature</p></div><div class="cAF"><p class="cAF">Treatment of venous thromboembolism in pregnancy [unlicensed
indication], <span class="cU">by subcutaneous injection</span>, early pregnancy
body-weight under 50 kg, 40 mg (4000 units) twice daily; body-weight
50–70 kg, 60 mg (6000 units) twice daily; body-weight 70–90 kg, 80 mg
(8000 units) twice daily; body-weight over 90 kg, 100 mg (10 000 units)
twice daily</p></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2773.htm">Previous: DALTEPARIN SODIUM</a> | <a class="top" href="2776.htm#">Top</a> | <a accesskey="]" href="2777.htm">Next: TINZAPARIN SODIUM</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>